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Abstract
Inflammation is a physiological response of the innate immune system against 
several endogenous or exogenous stimuli. Inflammation begins with an acute pat-
tern; however, it can become chronic by activating the adaptive immune response 
through cellular and noncellular mechanisms. The main etiologic factor of periodon-
tal disease is bacteria which substantially harbor the human oral cavity. The most 
common periodontal diseases are gingivitis and periodontitis, whose main charac-
teristic is inflammation. The knowledge of how immune mechanisms and inflam-
matory responses are regulated is fundamental to understanding the pathogenesis of 
periodontal disease. The purpose of this chapter is to show the current panorama of 
the immunological mechanisms involved in the pathogenesis of periodontal disease.
Keywords: periodontal tissues, biofilm, inflammatory response,  
innate and adaptive immunity, periodontitis
1. Introduction
Periodontitis is a globally widespread pathology of the human oral cavity. 
Approximately 10% of the global adult population is highly vulnerable to severe 
periodontitis, and 10–15% appears to be completely resistant to it, while the 
remainder varies between these two situations [1]. Periodontitis is a major public 
health problem due to its high prevalence, as well as because it may lead to tooth 
loss and disability, negatively affect chewing function and aesthetics, be a source of 
social inequality, and impair the quality of life. Periodontitis accounts for a substan-
tial proportion of edentulism and masticatory dysfunction, results in significant 
dental care costs, and has a plausible negative impact on general health [2].
2. Periodontal support tissues
The periodontium is a complex of tissues with blood vessels, nerves, and 
bundles of fibers, which provide nutrition and sensibility, supporting and invest-
ing the tooth. The periodontium has the potential for regeneration and remodel-
ing throughout life, which allows the primary dentition to be transient and to be 
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replaced by the permanent dentition [3, 4]. It is important to understand that each 
of the periodontal tissues has a very specialized structure and that these structural 
characteristics directly define the function. In fact, the proper functioning of the 
periodontium is only achieved through the structural integrity and interaction 
between its components [4].
The periodontium is one of the morphofunctional components of the stomato-
gnathic system, and its “design” not only responds to intrinsic functions related to 
nutrition or the subjection of the tooth but also to functions integrated within the 
physiology of the stomatognathic system [5]. The main function of the periodon-
tium is to join the tooth to the bone tissue and maintain integrity on the surface 
of the masticatory mucosa of the oral cavity [6]. The periodontium includes four 
tissues located near the teeth: (1) the alveolar bone (AB), (2) root cementum (CR), 
(3) periodontal ligament (PL), and (4) gingiva (G) (e.g., Figure 1a) [4, 7, 8].
2.1 Alveolar bone
The alveolar bone, together with the root cementum and the periodontal 
ligament, constitutes the tooth insertion apparatus, whose main function is to 
distribute the forces generated by chewing and other contacts [6]. The maxilla and 
mandible of the adult human can be subdivided into two parts: (a) the alveolar 
process that involves in housing the roots of the erupted teeth and (b) the basal 
body that does not involve in housing the roots [8].
Figure 1. 
Periodontal tissues. (a) Tissues that support the tooth include the alveolar bone (AB), root cementum (RC), 
periodontal ligament (PL), and gingiva (G). (b) Forms of cementum: acellular afibrillar cementum (AAC), 
acellular extrinsic fibers cementum (AEFC), cellular mixed stratified cementum (CMSC), and cellular 
intrinsic fibers cementum (CIFC). (c) Bundles of collagen fibers: crestal alveolar fibers (CAF), horizontal 
fibers (HF), oblique fibers (OF), and apical fibers (AF). (d) Parts of the gingiva: free gingiva (FG), 
interdental gingiva (IG), and attached gingiva (AG).
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The alveolar process is the bone of the jaws that contain the sockets (alveoli) 
of the teeth. It consists of outer cortical plates (buccal, lingual, and palatal) of the 
compact bone, a central spongiosa, and bone lining the alveolus (alveolar bone) 
[4]. The alveolar process is dependent on the teeth as they develop and remodel 
with their formation and eruption. Therefore, the shape, location, and function 
of the teeth determine its morphology [8]. The periodontal ligament contains 
progenitor cells that can differentiate into osteoblasts for the maintenance and 
repair of the alveolar bone. However, in the absence of the tooth, it is lost. These 
characteristics suggest that the regulatory mechanisms are important for the 
alveolar bone, so there is an interdependence of the periodontal tissues, which 
work together as a unit [4].
2.2 Root cementum
The root cementum is an avascular mineralized connective tissue covering 
the entire root surface, forming the interface between the root dentine and the 
periodontal ligament [6, 7]. In addition, the root cementum plays important 
roles in nourishing the tooth as well as in stabilizing the tooth via the attachment 
to the periodontal ligament. This enables the tooth to maintain its relationship 
to adjacent and opposing teeth [3]. Unlike the bone, the root cementum does 
not contain blood or lymphatic vessels, lacks innervation, and does not undergo 
remodeling or physiological resorption, but it is characterized by the fact that 
continues to be deposited throughout life [6]. The composition of cementum 
contains about 50% mineral (substituted apatite) and 50% organic matrix. Type 
I collagen is the predominant organic component, constituting up to 90% of the 
organic matrix. Other collagens associated with cementum include type I, III, V, 
VI, XII, and XIV [4].
Cementum performs different functions: it fixes the main fibers of the peri-
odontal ligament to the root and contributes in the repair process when the root 
surface has been damaged [6]. Cementum has been classified as cellular and acel-
lular cementum depending on the presence and absence of cementocytes, further 
grouped into intrinsic and extrinsic fiber cementum depending on the presence of 
collagen fibers formed by cementoblasts or by fibroblasts, respectively [8]. There 
are different forms of cementum (e.g., Figure 1b): (1) acellular afibrillar cementum 
(AAC), (2) acellular extrinsic fiber cementum (AEFC), (3) cellular mixed stratified 
cementum (CMSC), and (4) cellular intrinsic fibers cementum (CIFC) [4, 6].
2.3 Periodontal ligament
The periodontal ligament is the soft and specialized connective tissue situated 
between the cementum covering the root of the tooth and the bone forming the 
socket wall (alveolodental ligament) [4]. The periodontal ligament consists of cells 
and an extracellular compartment comprising collagenous and noncollagenous 
matrix constituents. The cells include osteoblasts and osteoclasts, fibroblasts, 
epithelial cell rests of Malassez, monocytes and macrophages, undifferentiated 
mesenchymal cells, and cementoblasts and odontoclasts. The extracellular com-
partment consists mainly of well-defined collagen fiber bundles embedded in an 
amorphous background material, known as ground substance [4, 8]. These bundles 
of collagen fibers can be classified into the following groups, according to their 
disposition (e.g., Figure 1c): crestal alveolar fibers (CAF), horizontal fibers (HF), 
oblique fibers (OF), and apical fibers (AF) [6].
The main function of the periodontal ligament is to support the teeth in their 
sockets and at the same time allow them to withstand the considerable forces of 
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mastication. In addition, the periodontal ligament has the capacity to act as a sensory 
receptor necessary for the proper positioning of the jaws during mastication, and, very 
importantly, it is a cell reservoir for tissue homeostasis, regeneration, and repair [4].
2.4 Gingiva
Gingiva is a portion of the oral mucosa covering the tooth-carrying part of the 
alveolar bone and the cervical neck of the tooth. Three parts of the gingiva can 
be distinguished (e.g., Figure 1d): (1) free gingiva (FG), (2) interdental gingiva 
(IG), and (3) attached or inserted gingiva (AG) [6]. Histologically, the epithelial 
component of the gingiva shows regional morphological variations that reflect the 
adaptation of the tissue to the tooth and alveolar bone. These include the epithelium 
that covers a connective tissue, chorion, or lamina propria. A keratinized stratified 
squamous epithelium protects the lamina propria of the gingiva on its masticatory 
surfaces and a nonkeratinized epithelium protects the lamina propria on its crevicu-
lar and junctional surfaces [6, 9]. The junctional epithelium plays a crucial role since 
it essentially seals off periodontal tissues from the oral environment. Its integrity is 
thus essential for maintaining a healthy periodontium. Periodontal disease sets in 
when the structure of the junctional epithelium starts to fail, an excellent example 
of how structure determines function [4].
During pathological conditions, such as inflammation, the periodontal con-
nective tissues, including the gingiva, undergo many changes. Clinically detected 
gingival overgrowth is one of the alterations that occurs in chronic periodontitis. 
It is caused by a variety of etiological factors and is exacerbated by local bacterial 
biofilm accumulation, because the periodontopathogen products act on the gingival 
tissues activating cellular events that induce the alteration of connective tissue 
homeostasis and the destruction of the alveolar bone [9]. Likewise, junctional 
epithelial cells differ considerably from those of the gingival epithelium. There are 
polymorphonuclear leukocytes and monocytes that pass from the subepithelial 
connective tissue through the junctional epithelium and into the gingival sulcus. 
The mononuclear cells, together with molecules they secrete and others originating 
from junctional epithelial cells, blood and tissue fluid, represent the first line of 
defense in the control of the perpetual microbial challenge [4].
3. Periodontal pathogenesis
Periodontitis is a chronic multifactorial disease characterized by an inflam-
mation of the periodontal tissue mediated by the host, which is associated with 
dysbiotic plaque biofilms, resulting in the progressive destruction of the tooth-
supporting apparatus and loss of periodontal attachment [1, 10]. The bacterial 
biofilm formation initiates gingival inflammation; however, periodontitis initiation 
and progression depend on dysbiotic ecological changes in the microbiome in 
response to nutrients from gingival inflammatory and tissue breakdown products 
and anti-bacterial mechanisms that attempt to contain the microbial challenge with 
in the gingival sulcus area once inflammation has initiated. This leads to the activa-
tion of several key molecular pathways, which ultimately activate host-derived 
proteinases that enable loss of marginal periodontal ligament fibers, apical migra-
tion of the junctional epithelium, and allows apical spread of the bacterial biofilm 
along the root surface [1]. Therefore, the primary features of periodontitis include 
the loss of periodontal tissue support, manifested through clinical attachment loss 
and radiographically assessed alveolar bone loss, presence of periodontal pocketing, 
and gingival bleeding [10].
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3.1 Periodontal histopathology
The development of gingivitis and periodontitis can be divided into a series 
of stages: initial, early, established, and advanced lesions (e.g., Figure 2) [11, 12]. 
The initial lesion begins 2–4 days after the accumulation of the microbial plaque. 
During the initial lesion, an acute exudative vasculitis in the plexus of the venules 
lateral to the junctional epithelium, migration of polymorphonuclear (PMN) cells 
through the junctional epithelium into the gingival sulcus, co-exudation of fluid 
from the sulcus, and the loss of perivascular collagen were observed. The early 
injury develops within 4–10 days. This lesion is characterized by a dense infiltrate of 
T lymphocytes and other mononuclear cells, as well as by the pathological alteration 
of the fibroblasts [6, 11–13].
Subsequently, the established lesion develops within 2–3 weeks. This lesion is 
dominated by activated B cells (plasma cells) and accompanied by further loss 
of the marginal gingival connective tissue matrix, but no bone loss is yet detect-
able. Several PMN continue to migrate through the junctional epithelium, and the 
gingival pocket is gradually established. Finally, in the advanced lesion, plasma 
cells continue to predominate as the architecture of the gingival tissue is disturbed, 
together with the destruction of the alveolar bone and periodontal ligament. It is 
characterized by a conversion of junctional epithelium to the pocket epithelium, 
formation of denser inflammatory infiltrate composed of plasma cells and mac-
rophages, loss of collagen attachment to the root surface, and resorption of the 
alveolar bone [6, 11–13].
3.2 Immune responses in the pathogenesis of periodontal disease
In normal health conditions, periodontal tissues are capable of coping with 
the presence of bacteria through several mechanisms of the host immune system 
(e.g., Figure 3) [14]. However, when the balance between the infection control 
mechanisms and the subgingival biofilm is lost [15], which includes Porphyromonas 
Figure 2. 
Histopathological lesions of periodontal pathogenesis. Initial, early, established, and advanced lesions of the 
development of gingivitis and periodontitis.
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gingivalis, Aggregatibacter actinomycetemcomitans, Tannerella forsythia, and Treponema 
denticola [16], innate, inflammatory, and adaptive reactions are triggered. These 
processes result in the destruction of the tissues that surround and support the teeth, 
and eventually in the loss of tissues, bones and finally, of the teeth [17].
3.2.1 Innate immune response in periodontal disease
The most important characteristic of periodontitis is the inflammatory 
reabsorption of the tooth-supporting alveolar bone due to the uncontrolled host 
immune response against periodontal infection, since the destructive events, 
which lead to the irreversible phenotype of periodontal disease, are the result of 
the persistence of a chronic and exacerbated inflammatory immune response [18]. 
Inflammation is a process of the innate immune system activation, in response to 
exogenous and endogenous factors, such as infection by microorganisms, tissue 
stress, and injuries. Inflammation is a protective response, characterized by its 
cardinal signs, such as redness, swelling, heat, pain, and disrupted function [19]. 
The inflammatory response consists of four main components: (1) endogenous or 
exogenous factors, such as molecular patterns associated with pathogens (PAMP) 
and damage (DAMP), which are derived from bacteria, viruses, fungi, parasites, 
and cell damage, as well as toxic cellular components or any other harmful condi-
tion; (2) cellular receptors that recognize these molecular patterns (PRR), for 
example, Toll-like receptors (TLR); (3) proinflammatory mediators, such as cyto-
kines, chemokines, the complement system, etc.; and (4) target cells and tissues, 
where these proinflammatory mediators act [20, 21]. The inflammatory response 
is mainly characterized by four successive phases: (1) silent phase, where the cells 
synthesize and release the first proinflammatory mediators; (2) vascular phase, 
characterized by an increase in vascular permeability and dilatation; (3) cellular 
Figure 3. 
Innate and adaptive immune response during periodontal disease (description in the text).
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phase, characterized by the infiltration of inflammatory cells at the site of injury; 
and (4) the resolution of the inflammatory response [22].
The inflammatory immune response is triggered by the interaction of resident 
cells with the bacterial biofilm attached to the tooth surface. Bacterial biofilm 
attaches to the tooth surface, making it impossible for the immune system to 
eradicate the infecting microorganisms efficiently, perpetuating the insult to the 
periodontal tissues [18]. The junctional epithelium is the first periodontal structure 
to face the bacterial challenge [23]. Bacteria are capable to cross the junctional 
epithelium and pass to the gingival conjunctive tissue, where they stimulate the 
gingival epithelial cells and fibroblasts to trigger the initial inflammatory responses 
[24]. These resident periodontal cells detect bacterial PAMP, such as lipopolysac-
charide (LPS) [25], which binds to the Toll-like receptors (TLR4/2), triggering 
the recruitment of several protein kinases in the cytoplasmic end of the receptors, 
ultimately causing the activation of proinflammatory transcription factors, such as 
nuclear factor kappa B (NFκB) and activator protein 1 (AP-1) [26], which induces 
the synthesis and release of mediators to trigger the inflammatory response. 
Likewise, the gingival fibroblasts and the periodontal ligament are responsible for 
the destruction and disorganization of the fibrous component of the extracellular 
matrix of the periodontal tissue by increasing the local production and the activity 
of the matrix metalloproteinases (MMPs) [27, 28].
The periodontal lesion is initiated as acute inflammation characterized by 
increased numbers of neutrophils migrating into the gingival crevice through the 
junctional epithelium, which have the de novo biosynthetic capacity for chemo-
kines and cytokines with proinflammatory, anti-inflammatory, or immunoregula-
tory properties. Neutrophils, through the release of chemokines, can induce the 
recruitment of interleukin-17-producing CD4-positive T-helper 17 cells to sites of 
infection or inflammation. In addition, they can promote the survival, prolifera-
tion, and development of B cells into antibody-secreting plasma cells. Likewise, it 
was shown that activated neutrophils express membrane-bound receptor activator 
of nuclear factor kappa Β ligand (RANKL), a key osteoclastogenic cytokine and, 
thereby able of inducing osteoclastic bone resorption [29]. These recent concepts 
suggest that neutrophils could contribute to periodontitis not only by initiating the 
lesion but also by participating in its progression, by recruiting T-helper 17 cells 
or promoting the accumulation of B cells and plasma cells in the established and 
advanced lesions.
Macrophages are an important source of proinflammatory and potentially 
destructive molecules for tissues, such as interleukin-1 (IL-1), tumor necrosis factor 
alpha (TNF-α), MMP, and prostaglandin E2 [30], which play an important role and 
are elevated in the gingival tissue and in the gingival crevicular fluid of patients 
with chronic periodontitis [28]. Therefore, studies have shown a direct correlation 
of macrophage infiltration with the severity of periodontal disease [31], contribut-
ing greatly to the intensification of the degradation of the collagen matrix in the 
connective periodontal tissue [32, 33]. These macrophages may undergo a classical 
(M1) or alternative (M2) activation. M1 macrophages are induced by microbial 
agents (e.g., LPS) or by Th1 cytokines and show high phagocytic capacity and an 
increased expression of proinflammatory cytokines, costimulatory, and antimi-
crobial molecules. In contrast, M2 macrophages are induced by Th2 cytokines 
and secrete high levels of IL-10 and transforming growth factor beta 1 (TGF-β1). 
Therefore, they have immunoregulatory properties and promote cell proliferation 
and tissue regeneration [29, 34]. In periodontal inflammation models, macrophages 
share properties of both M1 and M2. However, M1 macrophages show a predomi-
nance over M2 macrophages, suggesting that M1 macrophages probably represent a 
subset associated with periodontitis [35–37].
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3.2.2 Adaptive immune response in periodontal disease
When the inflammatory response becomes chronic, the lymphocytes of the 
adaptive immune system invade the periodontal tissues releasing inflammatory and 
immune molecular mediators, which alter the balance of bone metabolism, marking 
the transition from gingivitis to periodontitis [29]. The activation of lymphocytes 
requires two types of signals: a signal induced by the antigen receptor itself when 
recognizing its related antigen and a costimulatory signal by professional antigen-
presenting cells (APCs) [22]. In gingivitis, the predominant APCs are CD14+ and 
CD83+ dendritic cells. While in the periodontitis, the predominant APCs are CD19+ 
and CD83+ B lymphocytes [38]. Therefore, the activation of adaptive immunity 
has a great influence on the bone loss in periodontitis, associated with B and T 
lymphocytes, since several studies have shown that these cells are the main cellular 
sources of activator of the κB ligand receptor of the nuclear factor (RANKL) during 
periodontal inflammation [39].
RANKL is a cytokine member of the TNF family that can be bound or secreted to 
the membrane and stimulates the differentiation of osteoclasts, cell fusion, and acti-
vation that leads to bone resorption [40, 41]. Osteoblasts and stromal cells of the bone 
marrow predominantly express RANKL bound to the membrane, which induces 
osteoclastogenesis through cell contact with osteoclast precursors. Likewise, activated 
T and B cells produce both the membrane-bound and soluble RANKL forms. Soluble 
RANKL can induce osteoclastogenesis independently of direct contact between 
infiltrating lymphocytes and osteoclast precursors on the bone surface. However, 17 
T-helper cells expressing RANKL, but not T-helper 1 cells, activate osteoclasts also 
by direct cell-cell contact [42]. In the alveolar bone, the RANKL/OPG/RANK system 
controls the balance of the bone metabolism [43]. RANKL is the osteoclasts activator 
and the molecular signal directly responsible for the bone resorption, which interacts 
with its associated receptor RANK on the surface of osteoclast and osteoclast precur-
sors, which triggers its recruitment on the bone surface and cell fusion and activation 
[44]. Osteoprotegerin (OPG) is a soluble protein that has the ability to block the 
biological functions of RANKL by competitive inhibition [45]. In periodontitis, the 
increase in RANKL/OPG promotes the recruitment of osteoclast precursors, their 
fusion, and subsequent activation, leading to bone resorption [46].
On the other hand, Th1 lymphocytes have a fundamental role in the establish-
ment and progression of periodontitis, through the increase of IFN-γ levels [18]. 
Studies have shown that mice IFN-γ-deficient showed low levels of inflammatory 
cytokines and chemokines, as well as macrophages infiltrated in periodontal tissue, 
developing a less severe phenotype of alveolar bone destruction [47]. IL-1β and 
TNF-α are cytokines secreted by Th1 lymphocytes. TNF-α and IL-1β produce vaso-
dilation, stimulate the activation of endothelial cells to increase the recruitment of 
immune cells, increase the chemokines production in most cell types, participate in 
the activation of neutrophils, and stimulate secretion and tissue activation of MMPs, 
among other functions. Although neither IL-1β nor TNF-α is directly involved in the 
stimulation of bone resorption, they indirectly promote bone destruction by stimu-
lating sustained inflammation of the periodontal tissue [48]. Th2 lymphocytes are 
the main cellular source of IL-4, which promotes the change of class to the secretion 
of IgE in B cells and favors the alternative activation of macrophages in an IFN-γ-
independent pathway. These effector functions of the Th2 lymphocytes negatively 
regulate the inflammatory and Th1 lymphocyte responses, so that the polarization 
of a Th2-type immune response in periodontitis may represent a damaged adaptive 
immune response [18, 49]. Finally, RANKL can also be secreted by Th17 lympho-
cytes, which in cooperation with inflammatory cytokines derived from Th1 lympho-
cytes are capable to tilt bone metabolism favoring bone resorption [50].
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4. Conclusion
The main etiological factor of periodontal disease is the bacteria, which are 
capable of activating the innate immune response of the host inducing an inflam-
matory response. The evolution of this inflammatory response culminates in the 
destruction of periodontal tissues. For this reason, it is important to understand 
the different molecular and cellular mechanisms of the pathogenesis of periodontal 
disease, with the purpose of making an opportune diagnosis and appropriate treat-
ment and prognosis.
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